{"organizations": [], "uuid": "5ac333d0151712046698b52ed77cc47b61c08710", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180125.html", "section_title": "Archive News &amp; Video for Thursday, 25 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/ast-farma-ma-dechra-pharma/uks-dechra-to-buy-dutch-firms-ast-farma-le-vet-for-340-mln-euros-idUSL4N1PK2U5", "country": "US", "domain_rank": 408, "title": "UK's Dechra to buy Dutch firms AST Farma, Le Vet for 340 mln euros", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-01-25T15:36:00.000+02:00", "replies_count": 0, "uuid": "5ac333d0151712046698b52ed77cc47b61c08710"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/ast-farma-ma-dechra-pharma/uks-dechra-to-buy-dutch-firms-ast-farma-le-vet-for-340-mln-euros-idUSL4N1PK2U5", "ord_in_thread": 0, "title": "UK's Dechra to buy Dutch firms AST Farma, Le Vet for 340 mln euros", "locations": [], "entities": {"persons": [{"name": "le vet", "sentiment": "negative"}, {"name": "dechra", "sentiment": "none"}, {"name": "gopakumar warrier", "sentiment": "none"}, {"name": "justin george varghese", "sentiment": "none"}], "locations": [{"name": "uk", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "ast farma", "sentiment": "negative"}, {"name": "dechra pharmaceuticals plc", "sentiment": "negative"}, {"name": "dechra", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) - Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Europe-focused Le Vet for 340 million euros ($422.1 million) in a cash and share deal.\nThe debt-free, cash-free deal will see Dechra paying about 75 percent in cash and 25 percent in new Dechra shares, and subject to a two year lock-in, Dechra said in a statement.\n$1 = 0.8055 euros Reporting By Justin George Varghese in Bengaluru; Editing by Gopakumar Warrier\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-25T15:36:00.000+02:00", "crawled": "2018-01-26T21:45:43.013+02:00", "highlightTitle": ""}